Other Clinical Trial - EUS-FNA for Patients Taking Anticoagulants Without

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05437497` - Safety and Efficacy Evaluation of Remimazolam for Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT05437497 - Safety and Efficacy Evaluation of Remimazolam for Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02977650
Study type	Observational [Patient Registry]
Source	Hokkaido Pancreatobiliary Endoscopic Intervention Study Group
Contact	Kazumichi Kawakubo, Ph.D.
Phone	117161161
Email	kkawakubo-gi@umin.ac.jp
Status	Recruiting
Phase	N/A
Start date	November 2016

EUS-FNA for Patients Taking Anticoagulants Without Heparin Bridge

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms